SavedAdd your journal

Journals / Bakırköy Tıp Dergisi / 2017 / Cilt: 13 - Sayı: 2

A case of occured supraventricular tachycardia based on WPW triggered with chlorpheniramine and phenylephrine in newborn period

Yenidoğanda Klorfeniramin ve Fenilefrinin Tetiklediği, WPW Temelinde Gelişmiş Supraventriküler Taşikardi Olgusu

Levent KORKMAZ
Abdullah ÖZYURT
Osman BAŞTUĞ
Hülya HALİS
Ali BAYKAM
Mehmet Adnan ÖZTÜRK
Selim KURTOĞLU
Pages
102–106
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we present a case of SVT developed on the basis of WPW which is the result of the use of phenylephrine in neonatal period

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Supraventricular tachycardia (SVT) is the most common cardiac arrhythmia in childhood and neonatal period.
📊
Key Findings & Data:It is defined as 1: 200-250 in this period.
💡
Conclusion & Impact:In this article, we present a case of SVT developed on the basis of WPW which is the result of the use of phenylephrine in neonatal period
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Supraventricular tachycardia (SVT) is the most common cardiac arrhythmia in childhood and neonatal period. It is defined as 1: 200-250 in this period. Clinical findings in the newborns are heavier and may be come across as heart failure and hydrops fetalis. 10-20% of cases have Wolf Parkinson White (WPW) paternity. Sometimes it can cause morbidity and mortality in neonatal period due to drug-resistant and recurrent episodes. In this article, we present a case of SVT developed on the basis of WPW which is the result of the use of phenylephrine in neonatal period

Özet

Yenidoğanda klorfeniramin ve fenilefrinin tetiklediği, WPW temelinde gelişmiş supraventriküler taşikardi olgusuSupraventriküler taşikardi (SVT) çocukluk çağı ve yenidoğan döneminde en sık karşılaşılan kardiak aritmidir. Bu dönemde 1:200-250 oranında tanımlanmaktadır. Yenidoğanlarda klinik bulgular daha ağır olup kalp yetersizliği ve hidrops fetalis şeklinde karşımıza çıkabilir. Vakaların %10-20'sinde Wolf Parkinson White (WPW) paterni mevcuttur. Bazen ilaçlara dirençli ve yineleyebilen ataklar nedeniyle yenidoğan döneminde morbidite ve mortaliteye neden olabilir. Bu yazıda yenidoğan döneminde fenilefrin kullanımı sonucu WPW zemininde gelişmiş bir SVT olgusu sunulmuştur

🔖

Cite This Article

KORKMAZ, L., ÖZYURT, A., BAŞTUĞ, O., HALİS, H., BAYKAM, A., ÖZTÜRK, M. A., KURTOĞLU, S. (2017). A case of occured supraventricular tachycardia based on WPW triggered with chlorpheniramine and phenylephrine in newborn period. Bakırköy Tıp Dergisi, Cilt: 13 - Sayı: 2, 102–106. https://ajindex.com/articles/128493

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Moak JP. Supraventricular tachycardia in the neonate and infant. Prog Pediatr Cardiol 2000; 11: 25-38
  2. Srinivasan S, Strasburger J. Overview of fetal arrhythmias. Curr Opin Pediatr 2008; 20: 522-531
  3. Kantoch MJ. Supraventricular tachycardia in children Indian J Pediatr 2005; 72:609-19
  4. Erica L. Liebelt Cyclic Antidepressants. In: Goldfrank LR (Eds). Goldfrank’s Toxicologic Emergencies, 8th ed. Stanford, CT, Appleton&Lange, 2006: p. 1084-1094
  5. Strasburger JF, Cheulkar B, Wichman HJ. Perinatal arrhythmias: diagnosis and management. Clin Perinatol 2007; 34: 627-652
  6. Nilay H, Aydın M, Örün UA, Kanık S, İpek MŞ, Okumuş N, Zenciroğlu A. Yenidoğan Döneminde Farklı Klinik Sunumlarla Başvuran İki Wolff-Parkinson-White Sendromu Vakası. Çocuk Dergisi 2011; 11: 81-85
  7. Park MK. Cardiac arrhytmias. In: Park MK. Pediatric Cardiology for Practitioners. 5th ed. Philedelphia, USA: Mosby Elsevier Pres, 2008: p. 417-444
  8. Gilljam T, Jaeggi E, Gow RM. Neonatal supraventricular tachycardia: outcomes over a 27-year period at a single institution. Acta Paediatr 2008; 97: 1035-1039
  9. Balaguer Gargallo M, Jordán García I, Caritg Bosch J, Cambra Lasaosa FJ, Prada Hermogenes F, Palomaque Rico A. Supraventricular tachycardia in infants and children. An Pediatr 2007; 67: 133-138
  10. Ceviz N, Çeliker A. Çocuklarda Görülen Aritmilerin Farmakolojik Tedavisi. Türk Aritmi, Pacemaker ve Elektrofizyoloji Dergisi 2005; 32: 173-187
  11. Losek JD, Endom E, Dietrich A, Stewart G, Zempsky W, Smith K. Adenosine and pediatric supraventricular tachycardia in the emergency department: multicenter study and review. Ann Emerg Med 1999; 33: 185-191
  12. International Liaison Committee on Resuscitation (ILCOR). International Guidelines 2005 for CPR and ECG-a consensus on science. Circulation 2005; 112; 73-90
  13. Price JF, Kertesz NJ, Snyder CS, Fenrich AL. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children less than 1 year of age. J Am Coll Cardiol 2002; 39: 517-520
  14. American Heart Association (AHA) Guidelines for CPR and ECG. Circulation 2005; 112; IV-67-IV-77
  15. Sanatani S, Potts JE, Reed JH, et al. The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants. Circ Arrhythm Electrophysiol 2012; 5: 984-991
  16. O’Sullivan JJ, Gardiner HM, Wren C. Digoxin o